Raffaele Di Giacomo, PhD· @sciqst · X·· 2026-04-19Score60
Reading
Immunotherapy: CAR-T in solid tumors, mRNA vaccines, TCR-T
局部 nivolumab · Oral pre-cancer clinical response 85%, 1-year clearance 82%
Body
Mesmerizing insights from #AACR26 on the use of genomic markers and ctDNA in understanding the efficacy of nivolumab for NSCLC. This could have significant implications for developing personalized treatment strategies in oncology. I wonder how these findings will impact future
Heat 1 · 0 likes · 1 reply · 0 reposts
Conference abstracts
Justine Panian, Lin Liu, Minya Pu, Emily Pittman, Samuel Pena, Archana Ajmera, Yu-Wei Chen, Christos Kyriakopoulos, Qian Qin, James Michael Randall, Tian Zhang, Joshua Michael Lang, Akash Patnaik, Rana R. McKay
Read the abstract →Source: Raffaele Di Giacomo, PhD · x.com